Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.

Of all lawsuits filed against patients in 2024 in one U.S. state, physician practices and other non-hospital healthcare entities accounted for 80% of cases. That’s a complete inversion from just six years prior.  

In the three or so years since it burst into healthcare, ambient AI scribe technology has run away with the win in the market-uptake race. What has been the return on investment in all those software packages? 

The U.S. Department of Justice said it worries its lawsuit could ultimately bankrupt the telehealth group, leaving little money for alleged victims. The company is said to have refused to cancel member accounts, forcing patients to file credit card disputes to get refunds. This is in addition to other arguably more serious accusations levied by the DOJ.

The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.

AI technologies have changed daily life for provider organizations and industry partners alike. Arguably the biggest single difficulty to emerge from the complex transformation is the risk of cybersecurity breaches. 

The recall is officially an early alert, as the syringes are part of surgical convenience kits—the rest of which are safe to use. The defective syringes risk causing fatal injuries to patients and must be discarded. 

The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.